相关实验视频

Updated: Jun 20, 2025

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

提高中国结核病治疗坚持率的设备的单位成本和成本效益

S Sweeney¹, K Fielding¹, X Liu²

¹London School of Hygiene & Tropical Medicine, London, UK.

|July 22, 2024

概括

像药物事件提醒监控器 (MERM) 这样的数字坚持技术显示低增量成本,但在中国结核病治疗中尚未具有成本效益. 通过更广泛的患者管理策略,成本效益可能会提高.

科学领域:

卫生经济学卫生经济学
公共卫生公共卫生
数字健康干预措施数字健康干预措施

背景情况:

坚持结核病 (TB) 药物治疗对于治疗成功至关重要.
数字合规技术有潜力,但缺乏成本效益的证据.
药物事件提醒监控器 (MERM) 是这样一种技术.

研究的目的:

评估MERM的成本效益与中国结核病治疗的标准护理相比.
分析实用,集群随机优越性试验的数据.

主要方法:

社会视角成本数据收集.
马尔科夫对20年时间的建模,使用3%的折扣率.
敏感性和场景分析,以探索不确定性.

主要成果:

MERM的增量成本为每名患者27.22美元.
概率灵敏度分析显示,成本效益的不确定性很大.
关键参数的变化对增量成本效益率产生了重大影响.

结论:

目前,MERM的低增量成本并没有转化为成本效益.
通过将其整合到更广泛的患者管理策略中,可以提高成本效益.
需要进一步的研究,以优化数字坚持技术的实施.

关键词:

中国中国中国中国.这一数据,就是在MERM中,MERM是MERM.数字坚持技术技术的数字坚持技术经济学经济学经济学药物事件提醒监视器监视器监视器结核病是一种肺结核病.

更多相关视频

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

相关概念视频

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...